The Melanocortin System: One Precursor, Five Receptors
POMC, alpha-MSH, and a receptor family whose distribution explains why non-selective agonists do several unrelated-looking things at once.
The melanocortin system is one of the more elegantly organised signalling families in physiology: one precursor protein, several peptide products, five receptors, and a set of functions that look unrelated until you see how they are distributed.
One precursor, several peptides
All melanocortins derive from proopiomelanocortin (POMC), a precursor protein cleaved by prohormone convertases into different products depending on the tissue. From POMC come alpha-MSH, beta-MSH, gamma-MSH, ACTH and beta-endorphin.
Alpha-MSH is the thirteen-residue peptide most relevant to the research peptide catalog, and its core message sequence — His-Phe-Arg-Trp — is the minimal fragment that retains receptor activity. Almost every synthetic melanocortin agonist is built around it.
Five receptors
| Receptor | Principal distribution | Associated function in the literature |
|---|---|---|
| MC1R | Melanocytes, immune cells | Pigmentation; anti-inflammatory signalling |
| MC2R | Adrenal cortex | Binds ACTH only, not MSH peptides |
| MC3R | Central nervous system, periphery | Energy homeostasis, inflammation |
| MC4R | Central nervous system | Appetite and energy balance |
| MC5R | Exocrine glands | Sebaceous secretion |
MC2R is the odd one out — it responds to ACTH and not to the MSH peptides, which is why melanocortin agonists built on the MSH message sequence do not activate the adrenal axis.
The selectivity problem
This receptor distribution is why melanocortin research is dominated by a single question. A non-selective agonist acts on pigmentation, appetite, inflammation and exocrine function simultaneously, because those are simply where the receptors are.
Melanotan II is the standard example: a cyclic alpha-MSH analogue that agonises MC1R, MC3R, MC4R and MC5R. Its usefulness as a broad probe and the difficulty of interpreting its effects are the same fact.
Later work therefore went into selective ligands — molecules that separate MC1R from MC4R activity — and that effort is a substantial part of the field’s history.
The anti-inflammatory branch
A separate line of research concerns the C-terminal tripeptide of alpha-MSH, KPV (Lys-Pro-Val). This fragment retains anti-inflammatory activity reported in the literature — including NF-κB modulation — while lacking the pigmentation activity of the parent, because it does not carry the His-Phe-Arg-Trp message sequence that MC1R recognises.
That dissociation is what makes KPV interesting as a research tool: it separates one arm of alpha-MSH’s activity from the rest. As a tripeptide it also has a transporter route, PepT1, that longer peptides lack.
What the family shares structurally
Synthetic melanocortin analogues repeatedly use the same modifications, and they are recognisable once you know them:
- Norleucine replacing methionine — isosteric, no sulfur, cannot oxidise
- D-phenylalanine in place of L — increases potency and resists proteolysis
- Lactam cyclisation — locks the backbone into the receptor-bound conformation
- Terminal acetylation and amidation — blocks exopeptidases at both ends
The tryptophan in the message sequence is the one handling consideration: it is the primary photodegradation target in these molecules, which makes amber vials proportionate rather than precautionary.
Our Melanotan II article and KPV article cover the two ends of this family in detail.
All compounds are supplied strictly for laboratory research. We do not provide dosing information and nothing here describes use in humans.
All products and information referenced are for in-vitro research and laboratory use only. Nothing here is medical advice, and no therapeutic claim is made or implied.